Vyvanse (lisdexamfetamine) prior authorization denied appeal
Stimulant for ADHD or BED
Typical PA criteria
- ADHD or binge eating disorder diagnosis
- Trial of generic stimulant in some plans
Why your PA was denied
- Generic step therapy required
- Quantity limit exceeded
Evidence that overturns the denial
- ✓DSM-5 diagnosis documentation
- ✓Prior generic trial history
- ✓Specialist letter
Generic lisdexamfetamine is now available; many plans require it first.
Free analysis identifies the cited policy and missing evidence. Then a finished letter that maps your chart to the criteria.
FAQ
Why was my Vyvanse (lisdexamfetamine) prior authorization denied?+
The most common reasons are: Generic step therapy required; Quantity limit exceeded. Your denial letter names the specific criteria you did not meet.
How do I appeal a Vyvanse (lisdexamfetamine) denial?+
File a written appeal within 180 days that cites the insurer's clinical policy, includes a letter of medical necessity from the prescriber, and documents the criteria the insurer requires.
What evidence overturns a Vyvanse (lisdexamfetamine) denial?+
DSM-5 diagnosis documentation; Prior generic trial history; Specialist letter.
What if the plan excludes Vyvanse (lisdexamfetamine) entirely?+
Plan exclusions are different from medical-necessity denials. Check the Summary Plan Description. If the drug is fully excluded, an appeal will not overturn it; you may need a formulary exception or manufacturer assistance program.
Other drugs
- Wegovy (semaglutide)
- Zepbound (tirzepatide)
- Ozempic (semaglutide)
- Mounjaro (tirzepatide)
- Saxenda (liraglutide)